Wellmarker Bio, a biotech company was established in December 2016 with the goal of bringing hope and to provide solutions to patients diagnosed with cancer. Mr. Dong-Hoon Jin, is currently the CEO of Wellmarker Bio and concurrently serves as a professor at University of Ulsan College of Medicine based in Asan Medical Center(AMC). His previous experience at the drug discovery center has paved the way for establishing Wellmarker Bio. During his past at the center, he conducted a wide range of research, including biomarker development for global pharmaceutical companies, and worked as a consultant for biotechnology companies. Thanks to his expertise and his research team’s profound know-hows in new drug development, the company is growing at a fast pace. 

Link: https://news.chosun.com/site/data/html_dir/2019/12/30/2019123002143.html